Events Calendar
In This Section
Most Read Stories
Family found dead in Ohio home
Robbers order bar patrons to empty pockets
Man gets 3 years in prison for having sex with horse
Sex-toy study at Duke University raises some eyebrows
Akron man turns himself in after authorities turn up heat
Get ready for detour, delays on Route 8
Man appears alive at own funeral
Blogs:
Pets:
Not 101 Dalmations…but close!
The Heldenfiles:
Friday Notebook
Patrick McManamon:
An agent's tale
Akron Zips:
No. 1 UA soccer remains perfect, Zips football defeats rival Flashes
Tribe Matters:
Tribe makes roster moves
Cleveland Browns:
Lewis doesn't like boycott
Kent State Sports:
Kent State falls to Akron, 20-28
Cleveland Cavaliers:
Gameblog: Cavs at Knicks
Buckeye Blogging:
Weekly ‘B’ Deck Report – New Mexico St.
Varsity Letters:
Wrestling, bowling teams prepare for season
All Da King's Men:
Bigger And Better Boondoggles
Blog of Mass Destruction:
The Shooter
Akron Law Café:
NEW U.S. Supreme Court Database
See Jane Style:
Muffle Your Muffler
Car Chase:
Perfect Weather for an Autumn Drive
Let's Talk Real Estate:
RUMORS: Downtown Restaurant Explosion
Ohio Travels with Betty:
Jack is looking for a trip to Southern Ohio the week of November 16.
Sound Check:
The Black Keys to perform benefit concert at Musica on November 27
HRLite House:
Personal Rant – Why People Do Not Live in Northeast Ohio
Akron Gamer:
New 'Call of Duty' could set entertainment record
Published on Friday, Jul 18, 2008
Merck to settle
Vioxx lawsuits
Merck & Co. will start issuing checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits.
The decision marks the beginning of the end of the four-year legal saga, which began when cardiovascular side effects forced Merck to pull Vioxx off the market in 2004, triggering tens of thousands of lawsuits, sullying its reputation and forcing out its chief executive.
Energy prices fall;
stocks extend rally
Wall Street shot higher Thursday, extending its rally into a second session as tumbling energy prices bolstered an already upbeat mood that followed stronger-than-expected quarterly reports from big names like JPMorgan Chase and United Technologies. The Dow Jones industrial average rose 207.38 points, bringing its two-day advance to more than 480 points.
Investors got a double dose of good news after weeks of angst about the economy. Oil fell $5.31 to settle at $129.29 a barrel; it has dropped more than $15 in the past three sessions.
And early Thursday, three components of the Dow industrials — JPMorgan Chase & Co., United Technologies Corp. and Coca-Cola Co. — issued comments that generally indicated that their businesses are holding up despite sometimes difficult economic conditions.
Sherwin-Williams
profit down 15%
A weak housing market and higher material costs dragged Sherwin-Williams Co.'s second-quarter profit down 15 percent, the paint maker said. The company said it would raise prices for the third time this year.
Cleveland-based Sherwin-Williams also forecast that the still-souring housing sector would hamper its third-quarter results. But revenue and net income still managed to beat Wall Street forecasts.
The company earned a better-than-expected $171.7 million, or $1.45 per share, in the period ending June 30. That's down from a profit of $202.6 million, or $1.52 per share, in the same quarter last year. Revenue grew 1 percent to $2.23 billion, from $2.2 billion last year.
Cement producer,
Timken reach deal
Timken Co. of Canton announced a deal to supply bearings for vertical rolling mills operated by India's second-largest cement producer. Terms were not disclosed.
Merck to settle
Vioxx lawsuits
Get the full article here.
Comments
Click here to post your comments
